Sudden death associated with switching monoamine oxidase inhibitors.
A drug-free interval is often recommended when switching monoamine oxidase inhibitors, although the evidence firmly supporting this caution has been minimal. A case is reported where an abrupt change in monoamine oxidase inhibitor was followed by the death of a patient.
D003645:Death, Sudden / Q000209:etiology*; D005260:Female; D006801:Humans; D007520:Isocarboxazid / Q000506:poisoning; D008376:Maprotiline / Q000506:poisoning; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000506:poisoning*; D014268:Trifluoperazine / Q000506:poisoning
D008996:Monoamine Oxidase Inhibitors; D014268:Trifluoperazine; D008376:Maprotiline; D007520:Isocarboxazid